Abstract
Bromocriptine has been compared with an oestrogen and a placebo in the management of the inhibition of puerperal lactation. In addition to the resolution of symptoms, the effect on plasma prolactin levels has been studied. Of the regimes employed, bromocriptine was shown to have some advantage and a scheme indicating its place on the general treatment of this condition is outlined.
Get full access to this article
View all access options for this article.